Who is sponsoring NCT04533906?

NCT04533906 is sponsored by Marinomed Biotech AG.

What condition does NCT04533906 study?

NCT04533906 studies Common Cold, Viral Infection.

What drugs are being tested in NCT04533906?

Interventions: Coldamaris lozenges.

What is the status of NCT04533906?

NCT04533906 is currently COMPLETED.

Last reviewed 2021-01-08 · How we verify

Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Common Cold Viruses

NCT04533906 NA COMPLETED

Coldamaris lozenges are a medical device containing 10 mg carrageenan/lozenge. The goal of the study is to determine whether the iota-carrageenan content in the saliva of subjects who sucked Coldamaris® lozenges is sufficient to inhibit the replication of 4 of the most common respiratory viruses causing common cold. At least 29 subjects will be screened, in order to get 24 subjects included.

Details

Lead sponsor	Marinomed Biotech AG
Phase	NA
Status	COMPLETED
Enrolment	29
Start date	Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Common Cold
Viral Infection

Interventions

Coldamaris lozenges

Countries

Austria